Cluster Randomized Controlled Trial of a Patient and General Practitioner Intervention to Improve the Management of Multiple Risk Factors After Stroke Stop Stroke

被引:57
作者
Wolfe, Charles David Alexander [1 ,4 ]
Redfern, Judith
Rudd, Anthony George [2 ]
Grieve, Andrew Peter
Heuschmann, Peter Ulrich [3 ]
McKevitt, Christopher
机构
[1] Kings Coll London, Dept Primary Care & Publ Hlth Sci, Div Hlth & Social Care Res, London SE1 3QD, England
[2] St Thomas Hosp, Dept Hlth & Ageing, Guys & St Thomas NHS Fdn Trust, London, England
[3] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany
[4] Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London, England
基金
英国医学研究理事会;
关键词
smoking cessation; stroke; risk factors; SECONDARY PREVENTION; ISCHEMIC-STROKE; COMPLEX INTERVENTIONS; HEART-DISEASE; MINOR STROKE; FOLLOW-UP; CARE; POPULATION; RECURRENCE; PREDICTORS;
D O I
10.1161/STROKEAHA.110.588046
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Stroke is a major public health concern worldwide and survivors remain at high risk of recurrence. Secondary prevention requires management of multiple risk factors but current management is suboptimal. Evidence of the effectiveness of interventions to improve poststroke risk factor management from well-designed trials is limited. We assessed the effectiveness of a patient and general practitioner systematic follow-up intervention to improve risk factor management after stroke. Methods-We undertook a pragmatic cluster trial involving 523 consecutive incident stroke survivors identified using the population South London Stroke Register and registered with general practices in inner-city London. Practices were randomized to receive the intervention or usual care. The intervention entailed systematically identifying stroke survivors' risk factors for recurrence and providing tailored evidence-based management advice to general practitioners, patients, and caregivers at 10 weeks, 5 months, and 8 months poststroke. The primary outcome was management of key modifiable risk factors for stroke at 1 year with 3 end points: treatment with antihypertensive therapy, treatment with antiplatelet therapy, and smoking cessation. Hierarchical testing was used to adjust for multiple endpoints. Analysis was by intention to treat. This study is registered as number ISRCTN10730637. Results-The absolute risk reduction (and 95% CI) for each outcome was -3.7% (-13.0% to 5.6%) for treatment with antihypertensives; -2.3% (-12.0% to 7.6%) for treatment with antiplatelets; and -0.6% (-14.5% to 13.5%) for smoking cessation. Treatment effects were confirmed in the generalized linear model adjusting for clustering and predefined confounders. Conclusions-No improvement in risk factor management was demonstrated as a result of this patient, caregiver, and healthcare professional systematic follow-up system. Further evidence of how to effectively alter behavior of patients/caregivers and professionals is required if tailored information on risk and its treatment is to be of any clinical benefit. (Stroke. 2010;41:2470-2476.)
引用
收藏
页码:2470 / 2476
页数:7
相关论文
共 32 条
  • [1] Allen Kyle R, 2002, J Stroke Cerebrovasc Dis, V11, P88, DOI 10.1053/jscd.2002.127106
  • [2] Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework
    Ashworth, Mark
    Medina, Jibby
    Morgan, Myfanwy
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 : 1215 - 1218
  • [3] Cessation of smoking after first-ever stroke - A follow-up study
    Bak, S
    Sindrup, SH
    Alslev, T
    Kristensen, O
    Christensen, K
    Gaist, D
    [J]. STROKE, 2002, 33 (09) : 2263 - 2269
  • [4] Banet G A, 1997, J Vasc Nurs, V15, P29, DOI 10.1016/S1062-0303(97)90050-9
  • [5] Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services
    Coull, AJ
    Lovett, JK
    Rothwell, PM
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7435): : 326 - 328
  • [6] Developing and evaluating complex interventions: the new Medical Research Council guidance
    Craig, Peter
    Dieppe, Paul
    Macintyre, Sally
    Michie, Susan
    Nazareth, Irwin
    Petticrew, Mark
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7676): : 979 - 983
  • [7] The impact of stroke nurse specialist input on risk factor modification: a randomised controlled trial
    Ellis, G
    Rodger, J
    McAlpine, C
    Langhorne, P
    [J]. AGE AND AGEING, 2005, 34 (04) : 389 - 392
  • [8] *EUR STROK IN EX C, 2003, CEREBROVASC DIS, V16, P337
  • [9] Secondary prevention after ischemic stroke -: Evolution over time in practice
    Girot, M
    Mackowiak-Cordoliani, MA
    Deplanque, D
    Hénon, H
    Lucas, C
    Leys, D
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 (01) : 14 - 20
  • [10] Comparison of secondary vascular prevention in practice after cerebral ischemia and coronary heart disease
    Girot, M
    Deplanque, D
    Pasquier, F
    Destée, A
    Leys, D
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 (05) : 529 - 536